We build…

Gyes is a science-driven biotech company. We are exploring new frontiers in antibody drug discovery and development in cancer and immune and chronic inflammatory diseases.

… Multifunctional antibodies to combat disease

Precision antibody therapeutics

Gyes has developed the Multispecific Antibody Platform (the MAP): a set of phage-display libraries built to meet the highest standards of diversity, quality and developability.

Using the MAP, we discover and develop precision antibody therapeutics. Through their precise and multifunctional action, these antibodies can specifically affect disease-causing cells or strengthen the ability of immune cells to combat disease.

 

Our innovative antibodies are built to only become functional upon binding to combinations of targets co-expressed on select cell populations. In addition, we leverage grouping of receptors to potently activate cell signaling pathways.

… A network of companies

Gyes has created an engine of technology and expertise and uses this to build a network of companies to bring our multifunctional antibody therapeutics to the clinic.

Moirea

Moirea BV focuses on multifunctional antibodies that manipulate immune cells to combat cancer and auto­immune diseases.

Olethros

Olethros BV develops antibodies for deep-depletion of tissue-resident pathogenic immune cells in immune diseases.